[go: up one dir, main page]

Revision history of "Potent efficacy of metronomic topotecan and pazopanib combination therapy in preclinical models of primary or late stage metastatic triple-negative breast cancer" (Q36618871)

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

17 May 2022

  • curprev 15:2115:21, 17 May 2022 KrBot talk contribs 135,903 bytes −1 Set a claim value: title (P1476): Potent efficacy of metronomic topotecan and pazopanib combination therapy in preclinical models of primary or late stage metastatic triple-negative breast cancer undo
  • curprev 15:2115:21, 17 May 2022 KrBot talk contribs 135,904 bytes −1 Changed Dutch label: Potent efficacy of metronomic topotecan and pazopanib combination therapy in preclinical models of primary or late stage metastatic triple-negative breast cancer undo (restore)
  • curprev 15:2115:21, 17 May 2022 KrBot talk contribs 135,905 bytes −1 Changed English label: Potent efficacy of metronomic topotecan and pazopanib combination therapy in preclinical models of primary or late stage metastatic triple-negative breast cancer undo (restore)
  • curprev 15:2115:21, 17 May 2022 KrBot talk contribs 135,906 bytes −1 Changed Asturian label: Potent efficacy of metronomic topotecan and pazopanib combination therapy in preclinical models of primary or late stage metastatic triple-negative breast cancer undo (restore)

25 October 2021

26 June 2021

8 June 2020

14 January 2020

31 October 2019

24 January 2019

25 October 2018

20 September 2018

28 June 2018

30 September 2017

9 September 2017

15 August 2017